• SENSEX 81,911.01
    31.61 (+0.04%)
  • BANKNIFTY 61,518.50
    726.10 (+1.19%)
  • NSE
    1,994.50 1,994.50(%)
  • Reliance Industries
    1,342.10 1,611.20(%)
  • ICICI Bank
    1,592.20 1,616.70(%)
  • Kalyan Jewellers
    716.00 716.00(%)
  • Cupid
    389.00 389.00(%)
  • HDFC Bank
    813.90 1,017.90(%)
  • Sai Life
    1,881.05 786.15(%)
  • SBI
    1,089.00 1,234.80(%)
  • Kotak Mah. Bank
    494.00 494.00(%)
  • Page Industries
    31,752.10 29,800.00(%)
  • M & M
    3,369.00 2,743.15(%)
  • Gabriel India
    1,690.25 1,690.25(%)
  • Bharti Airtel
    2,071.35 1,726.05(%)
  • Cummins India
    4,311.70 6,142.80(%)
  • N S D L
    815.00 1,180.00(%)
  • Hind.Aeronautics
    4,738.80 3,479.20(%)
  • Avanti Feeds
    798.20 1,592.30(%)
  • Indegene
    672.00 672.00(%)
  • Lenskart Solut.
    738.30 767.40(%)
  • Hindustan Copper
    467.35 759.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Everest Organics Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4614.0
  • ISIN : INE334C01029
241.25 0 (-0.17%)
  • As on 12 Nov 2026 (EOD)

  • Today’s Low

    239.90

  • Today’s High

    255.40

  • Open

    244.15

  • Perv Close

    241.65

  • 52W Low

    197.00

  • 52W High

    536.40

Key Indicators

  • P/E(TTM)

    45.78

  • Mar.Cap (₹Cr.)

    240.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    79.69

  • Debt-Equity Ratio

    -0.17

  • AGM Date

    12-Nov-2026

  • EPS

    5.27

  • P/E Ratio

    45.78

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    240.62

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    9.97

  • BV (₹)

    79.70

  • Sales( ₹ in Cr.)

    196.16

  • NP (in Cr.)

    5.55

  • NP Var(%)

    530.0

  • Div%

    0.0

  • CPS (₹)

    12.10

  • EPS (₹)

    5.60

  • Traded Value (₹ in Lakhs)

    240.62

  • 52 Week High

    536.40

  • 52 Week Low

    197.00

  • Price BSE

    241.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    240.62

  • P/C Ratio

    20.00

  • P/E Ratio

    43.30

  • Price Vs.BV

    5.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 225.44 182.37 226.49 208.73 230.22 207.36
Excise Duty 29.28 22.89 29.25 25.69 30.17 25.79
Net Sales 196.16 159.48 197.24 183.04 200.05 181.57
Other Income 1.25 0.68 0.89 6.94 2.21 1.06
Stock Adjustments 1.95 -1.04 -0.56 3.23 4.51 8.22
Total Income 199.36 159.12 197.57 193.21 206.77 190.85
EXPENDITURE :            
Raw Materials 126.27 98.53 124.64 126.31 141.72 117.13
Power and Fuel Cost 12.90 14.83 15.40 18.88 14.70 12.36
Employee Cost 15.48 16.35 18.80 16.30 16.33 15.26
Other Manufacturing Expenses 11.54 10.85 15.37 13.66 15.80 13.91
Selling and Administration Expenses 9.27 9.11 10.52 9.75 8.66 7.65
Miscellaneous Expenses 2.84 1.52 0.96 0.44 0.92 0.64
Employee Benefit Expenses 15.48 16.35 18.80 16.30 16.33 15.26
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 178.30 151.20 185.69 185.35 198.13 166.94
Operating Profit 21.06 7.91 11.88 7.87 8.64 23.91
Interest 6.53 5.19 5.47 3.31 3.10 3.26
Gross Profit 14.53 2.72 6.41 4.56 5.54 20.65
Depreciation 6.48 5.96 5.80 4.47 3.80 3.37
Profit Before Tax 8.05 -3.24 0.61 0.09 1.74 17.28
Current Tax 2.26 0.00 0.10 0.02 0.29 3.02
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.24 -1.95 0.37 0.26 0.31 0.54
Reported Net Profit 5.55 -1.29 0.14 -0.18 1.14 13.72
Extraordinary Items 0.00 0.00 0.00 -0.10 0.00 0.00
Adjusted Net Profit 5.55 -1.29 0.14 -0.08 1.14 13.72
Adjustment below Net Profit 0.00 -1.60 0.00 0.00 -0.12 -0.14
P & L Balance brought forward 31.22 34.11 34.49 38.80 38.58 22.47
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.51 0.40 0.80 1.20
P & L Balance carried down 36.76 31.22 34.11 38.21 38.80 34.85
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 15.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 1.50
Earnings Per Share-Unit Curr 5.71 -1.33 0.17 -0.23 1.43 17.14
Earnings Per Share(Adj)-Unit Curr 5.71 -1.33 0.17 -0.23 1.43 17.14
Book Value 77.73 71.00 57.30 57.77 58.50 58.22
Book Value(Adj)-Unit Curr 77.73 71.00 57.30 57.77 58.50 58.22

Shareholding Pattern

  • Promoter Group

    60.61%

  • Public Share Holding

    39.39%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 168,261 168,261.00 168,261 168,261
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 168,261 1.69 168,261 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 3,949,262 39.60 3,949,262 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,927,452 19.33 1,664,295 6
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 5,876,714 58.92 5,613,557 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 2,214 0.02 2,214 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 36 0.00 36 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 2,250 0.02 2,250 3
2] Non Institution
Bodies Corporate 996,486 9.99 989,070 51
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 211,664 2.12 150,824 145
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 86,057 0.86 86,057 75
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,449,515 14.53 1,449,515 15
Individuals holding nominal share capital up to Rs. 1 lakh 1,169,863 11.73 930,355 7,489
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,926,458 39.37 3,618,694 7,779
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 9,973,683 100.00 9,402,762 7,792

Company Background

Everest Organics LtdPharmaceuticals - Indian - Bulk Drugs

  • Everest Organics Ltd
  • BSE Code : 4614.0
  • ISIN : INE334C01029

  • Incorporation Year

    1993

  • Registered Office

    Aroor Village
    Sadasivpet Mandal, Medak,
    Telangana-502291

  • Telephone

    91-8455-250113

  • FAX

    91-8455-250114

  • Chairman

    SUNDARA PRASAD VENKATA SATYA SRIKAKOLAPU

  • Managing Director

    Srikakarlapudi Sirisha

  • Company Secretary

  • Auditor

    P S N Ravi Shanker&Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Everest Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Abbott India 26,603.60 7,217.19 6,929.05 34.20 43.78
Astrazeneca Phar 6,431.20 2,304.07 2,275.58 90.47 27.86
Glaxosmi. Pharma 2,655.30 3,932.76 3,790.20 39.45 58.17
Evonile Pharma 1,583.60 393.10 354.33 -1,389.12 15.94
Cipla 1,410.00 20,102.60 18,979.95 42.97 13.88
Bliss GVS Pharma 641.15 773.53 729.81 41.80 12.51
Amrutanjan Healt 507.50 520.13 502.55 25.61 24.16
Fermenta Biotec. 472.10 474.15 450.25 22.31 18.77
Guj. Themis Bio. 388.05 168.25 165.82 103.76 18.05
Ambalal Sarabhai 36.76 19.52 3.94 62.31 6.77